Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy
Zhan Shi,1,* Sihui Zhu,2,* Yuncheng Jin,1 Liang Qi,1 Mingzhen Zhou,1 Ziyan Zhou,1 Juan Zhang,1 Baorui Liu,1 Jie Shen1 1Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University & Clinical Cancer Institute of Nanjing University,...
Main Authors: | Shi Z, Zhu S, Jin Y, Qi L, Zhou M, Zhou Z, Zhang J, Liu B, Shen J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-02-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/lymphocyte-to-c-reactive-protein-ratio-is-an-independent-predictor-of--peer-reviewed-fulltext-article-JHC |
Similar Items
-
Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
by: Hsiang CW, et al.
Published: (2021-10-01) -
Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
by: Jongmoo Park, et al.
Published: (2019-09-01) -
Effectiveness of individual audio-visual coaching, respiratory modulated stereotactic body radiotherapy for localized hepatocellular carcinoma: Analysis of 29 cases from a single academic radiotherapy center
by: Liang-Cheng Chen, et al.
Published: (2021-01-01) -
Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy
by: Wen-Yen Huang, et al.
Published: (2020-03-01) -
Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma
by: Mathew AS, et al.
Published: (2021-06-01)